Cargando…
IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation
New anti-inflammatory treatments are needed for CF airway disease. Studies have implicated the endoplasmic reticulum stress transducer inositol requiring enzyme 1α (IRE1α) in CF airway inflammation. The activation of IRE1α promotes activation of its cytoplasmic kinase and RNase, resulting in mRNA sp...
Autores principales: | Hull-Ryde, Emily A., Minges, John T., Martino, Mary E. B., Kato, Takafumi, Norris-Drouin, Jacqueline L., Ribeiro, Carla M. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002512/ https://www.ncbi.nlm.nih.gov/pubmed/33802742 http://dx.doi.org/10.3390/ijms22063063 |
Ejemplares similares
-
Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation
por: Ribeiro, Carla M. P., et al.
Publicado: (2017) -
Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation
por: Lara-Reyna, Samuel, et al.
Publicado: (2019) -
New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015) -
Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022) -
Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)